Publications of Johnny Kim

Maroli, G.; Scha, A.; Guenther, S.; -Gonzalez, C. G.; Rupp, S.; Schlierbach, H.; Chen, Y.; Graumann, J.; Wietelmann, A.; Kim, J. et al.; Braun, T.: Inhibition of autophagy prevents cardiac dysfunction at early stages of cardiomyopathy in Bag3-deficient hearts. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 193, pp. 53 - 66 (2024)

Zhu, Y.; Ackers-Johnson, M.; Shanmugam, M. K.; Pakkiri, L. S.; Drum, C. L.; Chen, Y.; Kim, J.; Paltzer, W. G.; Mahmoud, A. I.; Tan, W. L. W. et al.; Lee, M. C. J.; Jiang, J.; Luu, D. A. T.; Ng, S. L.; Li, P. Y. Q.; Wang, A.; Qi, R.; Ong, G. J. X.; Ng, T. Y.; Haigh, J. J.; Tiang, Z.; Richards, A. M.; Foo, R. S. Y.: Asparagine Synthetase Marks a Distinct Dependency Threshold for Cardiomyocyte Dedifferentiation. CIRCULATION 149 (23), pp. 1833 - 1851 (2024)

Vega-Sendino, M.; Luettmann, F. F.; Olbrich, T.; Chen, Y.; Kuenne, C.; Stein, P.; Tillo, D.; Carey, G. I.; Zhong, J.; Savy, V. et al.; Radonova, L.; Lu, T.; Saykali, B.; Kim, K.-P.; Domingo, C. N.; Schueler, L.; Guenther, S.; Bentsen, M.; Bosnakovski, D.; Schoeler, H.; Kyba, M.; Maity, T. K.; Jenkins, L. M.; Looso, M.; Williams, C. J.; Kim, J.; Ruiz, S.: The homeobox transcription factor DUXBL controls exit from totipotency. NATURE GENETICS (56), pp. 697 - 709 (2024)

Chen, Y.; Luttmann, F. F.; Schoger, E.; Schoeler, H. R.; Zelarayan, L. C.; Kim, K.-P.; Haigh, J. J.; Kim, J.; Braun, T.: Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice. SI 373 (6562), pp. 1537 - 1540 (2021)

Tan, D. S.; Chen, Y.; Gao, Y.; Bednarz, A.; Wei, Y.; Malik, V.; Ho, D. H.-H.; Weng, M.; Ho, S. Y.; Srivastava, Y. et al.; Velychko, S.; Yang, X.; Fan, L.; Kim, J.; Graumann, J.; Stormo, G. D.; Braun, T.; Yan, J.; Schoeler, H. R.; Jauch, R.: Directed Evolution of an Enhanced POU Reprogramming Factor for Cell Fate Engineering. MOLECULAR BIOLOGY AND EVOLUTION 38 (7), pp. 2854 - 2868 (2021)

Preussner, J.; Zhong, J.; Looso, M.; Braun, T.; Kim, J.: Connect-four: genomic analyses of regenerating stem cells identifies zygotic Dux factors as tumor initiators. MOLECULAR & CELLULAR ONCOLOGY 6 (2), e1565469 (2019)

Preussner, J.; Zhong, J.; Sreenivasan, K.; Guenther, S.; Engleitner, T.; Kuenne, C.; Glatzel, M.; Rad, R.; Looso, M.; Braun, T. et al.; Kim, J.: Oncogenic Amplification of Zygotic Dux Factors in Regenerating p53-Deficient Muscle Stem Cells Defines a Molecular Cancer Subtype. CELL STEM CELL 23 (6), pp. 794 - + (2018)